Literature DB >> 17937249

Susceptibility genes and the question of embodied identity.

Margaret Lock1, Julia Freeman, Gillian Chilibeck, Briony Beveridge, Miriam Padolsky.   

Abstract

Drawing on an assumption of the co-construction of the material and the social, late-onset Alzheimer's disease (AD) is used as an illustrative example to assess claims for an emergent figure of the "individual genetically at risk." Current medical understanding of the genetics of AD is discussed, followed by a summary of media and AD society materials that reveal an absence of gene hype in connection with this disease. Excerpts from interviews with first-degree relatives of patients diagnosed with AD follow. Interviewees hold complex theories of causation. After genetic testing they exhibit few if any subjective changes in embodied identity or lifestyle. Family history is regarded by interviewees as a better indicator of future disease than is genetic testing. We argue that, even when molecular genetics are better understood, predictions about complex disease based on genotyping will be fraught with uncertainty, making problematic the concept of individuals as genetically at risk when applied to late-onset complex disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17937249     DOI: 10.1525/maq.2007.21.3.256

Source DB:  PubMed          Journal:  Med Anthropol Q        ISSN: 0745-5194


  8 in total

1.  Enacting genetic responsibility: experiences of mothers who carry the fragile X gene.

Authors:  Kelly Raspberry; Debra Skinner
Journal:  Sociol Health Illn       Date:  2010-11-05

2.  Postgenomics, uncertain futures, and the familiarization of susceptibility genes.

Authors:  Gillian Chilibeck; Margaret Lock; Megha Sehdev
Journal:  Soc Sci Med       Date:  2010-05-08       Impact factor: 4.634

3.  Assessing the Psychological Impact of Genetic Susceptibility Testing.

Authors:  J Scott Roberts
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

4.  On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?

Authors:  Shoshana Shiloh; Christopher H Wade; J Scott Roberts; Sharon Hensley Alford; Barbara B Biesecker
Journal:  Med Decis Making       Date:  2012-11-05       Impact factor: 2.583

5.  Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease.

Authors:  Susan Hiraki; Clara A Chen; J Scott Roberts; L Adrienne Cupples; Robert C Green
Journal:  J Genet Couns       Date:  2008-10-23       Impact factor: 2.537

6.  After the revolution? Ethical and social challenges in 'personalized genomic medicine'

Authors:  Eric T Juengst; Richard A Settersten; Jennifer R Fishman; Michelle L McGowan
Journal:  Per Med       Date:  2012-06-01       Impact factor: 2.512

7.  A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocol.

Authors:  Pia Kirkegaard; Peter Vedsted; Adrian Edwards; Morten Fenger-Grøn; Flemming Bro
Journal:  BMJ Open       Date:  2013-03-01       Impact factor: 2.692

8.  Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study.

Authors:  Lynn Macrae; Alicia Navarro de Souza; Carmen G Loiselle; Nora Wong
Journal:  Hered Cancer Clin Pract       Date:  2013-10-16       Impact factor: 2.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.